The structural diversity of synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) has increased since the first examples were reported a decade ago.
piperazine derivative MEPIRAPIM (4) , reported in Japan in 2014, 31 likely inspired by a class of water-soluble cannabinoid analgesics developed by Schering-Plough. 32 The first putative SCRA NPS featuring a pyrrolidine ring at the 3-position were recently reported; indole 5F-PY-PICA (5) was identified in France in June 2015, 33 and the indazole analogue 5F-PY-PINACA (6) was notified in Sweden around the same time. 33 The metabolic profile of 5F-PY-PICA in rat and human hepatocytes was recently described, but nothing else is known of the pharmacology of this class of putative SCRA NPS. 34 Although there are obvious structural similarities to MEPIRAPIM, neither 5F-PY-PICA nor 5F-PY-PINACA had been described in the chemical literature prior to their detection on the NPS market. Pyrrolidine is a pendant structural feature of many psychoactive cathinones, 35 but 1-(5fluoropentyl)-1H-ind(az)ole-3-carboxamide is a common structural motif in SCRA NPS. The recent discovery in Spain of a phenethylamine featuring a popular SCRA functional group suggests that the design of NPS may not follow conventional rules for drug design, or that molecular hybridization is used in an ad hoc fashion to generate new compounds. 36 Since nothing is known of the chemistry or pharmacology of 5F-PY-PICA and 5F-PY-PINACA, the aim of the present work was to prepare and analytically characterize these emergent SCRAs and several "prophetic" analogues, and to evaluate their cannabinoid receptor affinities and activities in vitro and in vivo. Related analogues arising from expansion (7, 8) , or scission (9, 10) of the pyrrolidine ring were also prepared and evaluated to provide insight into structure-activity relationships (SARs) for this class. Additionally, several 5F-PY-PICA analogues featuring alternative 1-indole substituents commonly found in other SCRA classes were also prepared and characterized proactively. Specifically, analogues featuring a butyl (11) , pentyl (12) , 4- fluorobenzyl (13) , and cyclohexylmethyl (14) subunit were synthesized, based on current SCRA design trends.
Experimental. General chemical synthesis details. All reactions were performed under an atmosphere of nitrogen or argon unless otherwise specified. Dichloromethane, N,Ndimethylformamide (DMF), methanol, and toluene were anhydrous and used as purchased.
Triethylamine was distilled over calcium hydride. All other commercially available reagents General procedure for amidation of 1-alkyl-1H-indole-3-carboxylic acids. A solution of the appropriate carboxylic acid (0.5 mmol) in CH2Cl2 (1 mL) was treated with (COCl)2 (85 µL, 1.0 mmol, 2.0 equiv.) followed by DMF (1 drop). After stirring for 2 h, the solution was evaporated in vacuo, and the crude acid chloride was used immediately in the following step.
A cooled (0 °C) solution of the freshly prepared acid chloride (0.5 mmol) in CH2Cl2 (5 mL) was treated with Et3N (175 µL, 1.25 mmol, 2.5 equiv.), the appropriate amine (0.60 mmol, 1.2 equiv.), and stirred at ambient temperature for 14 h. The mixture was partitioned between CH2Cl2 (20 mL) and 1 M aq. HCl (10 mL). The layers were separated and the organic phase was washed with 1 M aq. HCl (2 × 10 mL), sat. aq. NaHCO3 (3 × 10 mL), brine (10 mL), dried (MgSO4), and the solvent evaporated under reduced pressure. The crude products were purified by flash chromatography unless stated otherwise. The total ion chromatogram (TIC) obtained from the LC-QTOF/MS run was analyzed using Agilent MassHunter Qualitative Analysis software (Agilent Technologies, Sta. Clara, CA). A search was done using the chemical formula of the expected material to confirm the identity and measure retention time of the major chromatogram peak. To confirm, the following criteria were imposed for a compound match: mass error ≤ 10 ppm; target score ≥ 70 (indication of isotopic pattern match) for peaks that did not exhibit detector saturation; and the presence of at least one expected fragment ion peak in its MS/MS spectra. MS/MS spectra were captured to assess the unique fragmentation of each parent cannabinoid.
In vitro cannabinoid receptor binding experiments. Experiments utilized human CB1 or CB2
tagged at the N-terminus with three haemagglutinin sequences (HA-hCB1, HA-hCB2) stably transfected into HEK 293. 44 In vitro cannabinoid receptor functional activity assay. Mouse AtT20 neuroblastoma cells stably transfected with human CB1 or human CB2 have been previously described. 43 Membrane potential was measured using a FLIPR Membrane Potential Assay kit (blue) from Molecular Devices, as described previously. 46 The dye was reconstituted with assay buffer of Biotelemetry transmitters (model TA-F10, Data Sciences International, St. Paul, MN) were implanted as previously described. 13 The transmitter was implanted according to the manufacturers protocol into the peritoneal cavity following anesthetization with isoflurane (3% induction, 1-2% maintenance). The wound was sutured closed and data collection commenced after 10 days of recovery.
The mice were habituated over multiple days to injections of vehicle (a solution composed of 7.8% polysorbate 80 and 92.2% physiological saline). Injection always occurred at a set time of day converting 23 to the corresponding acid chloride and treating with pyrrolidine, as described for the indoles 5 and 7-14 above, were unsuccessful.
[APPROXIMATE PLACEMENT OF 5F-PY-PICA, 5F-PY-PINACA, and analogues 7-14 were screened in competitive radioligand binding assays and fluorescence-based functional assays against CB1 and CB2 receptors (Table 1) .
Surprisingly, despite the detection of 5F-PY-PICA and 5F-PY-PINACA as putative NPS due to their presence in drug markets, neither compound exhibited high affinity for CB1 (or CB2) receptors, with less than 60% displacement of tritiated ligand for each compound at each receptor.
Additionally produced responses that were a substantial fraction of that produced by a maximally effective concentration of CP55,940 (1 µM). CP55,940 hyperpolarized AtT20-CB2 cells with a pEC50 of 7.45 ± 0.03, and a maximum decrease in fluorescence of 32 ± 1%. Several ligands produced substantial hyperpolarizations of AtT20-CB2 cells, but none had a maximum effect greater than 75% of CP55,940 at 1 µM. The largest activation of CB2 was induced by 8 (72 ± 3%).
The in vitro pharmacological profiles of 5F-PY-PICA and 5F-PY-PINACA indicate that these putative SCRAs have very low affinity and efficacy at CB1 receptors, and are unlikely to be psychoactive in humans. Similar to many SCRA NPS, both 5F-PY-PICA and 5F-PY-PINACA had substantial activity at CB2 receptors, but this is unlikely to mediate any discernable effects on mood in people.
To further characterize these compounds, and determine if they could be metabolized into active cannabinoids, we examined the effects of 5F-PY-PICA and 5F-PY-PINACA in mice using biotelemetry. The pharmacological effects of numerous SCRAs have been described in mice and rats, and include robust hypothermia, bradycardia, and hypolocomotion mediated by central CB1 agonist activity. [47] [48] [49] [50] [51] As anticipated from the in vitro pharmacological data, neither 5F-PY-PICA nor 5F-PY-PINACA produced physiological effects consistent with central CB1 activity, and hypothermic effects were not observed in mice at doses up to 10 mg/kg ( Figure 5 ). Many SCRAs, including JWH-018, AB-FUBINACA, MDMB-FUBINACA, and 5F-CUMYL-P7AICA, elicit hypothermic effects at doses of 1 mg/kg or below in this rodent model via a CB1 receptor-mediated mechanism. 13, 43, 52 Therefore, it can be concluded that neither 5F-PY-PICA nor 5F-PY-PINACA 
